Clinical trial
Maribavir Versus Oral Ganciclovir For The Prevention of Cytomegalovirus (CMV)…
NCT00497796 · Shire, Industry · Completed
Key facts
| NCT number | NCT00497796 |
|---|---|
| Title | Maribavir Versus Oral Ganciclovir For The Prevention of Cytomegalovirus (CMV) Disease in Liver Transplant Recipients |
| Official title | A Randomized, Double-blind Study To Assess The Efficacy And Safety Of Prophylactic Use Of Maribavir Versus Oral Ganciclovir For The Prevention Of Cytomegalovirus Disease In Recipients Of Orthotopic Liver Transplants |
| Lead sponsor | Shire, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cytomegalovirus Infections |
| Intervention type | Drug |
| Interventions | maribavir, ganciclovir |
| Enrollment | 307 |
| Start date | Jul 23, 2007 |
| Primary completion | Sep 14, 2009 |
| Completion | Sep 14, 2009 |
| First posted | Jul 9, 2007 |
| Last update posted | Jun 11, 2021 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: